New vaccine booster aims to shield against many coronaviruses

NCT ID NCT07113106

Ongoing ⭐️ VACCINE ⭐️ Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new booster vaccine called CD40.Pan.CoV in 48 healthy adults in France. The goal is to see if it is safe and can boost the body's defenses against multiple coronavirus variants. Participants receive one injection and are monitored for side effects and immune response for one month.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Locations

CIC 1403 CHU de Lille

Lille, 59037, France
CIC 1405 CHU Clermont Ferrand

Clermont-Ferrand, 63000, France
CIC 1413 CHU de Nantes

Nantes, 44093, France
CIC 1417 Cochin-Pasteur Hôpital Cochin

Paris, 75014, France
CIC 1427 Hôpital St Louis

Paris, 75475, France
Centre de Recherche Clinique CHU de Caen Normandie

Caen, 14033, France
Hôpital Henri Mondor

Créteil, 94010, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.